We're Keeping An Eye On Ventyx Biosciences' (NASDAQ:VTYX) Cash Burn Rate - Yahoo Finance
2025-01-10 • Google News
Ventyx Biosciences Inc (VTYX)
US$ 1.2-4.76%
Price Chart
Key Statistics
Market Cap
$ 99.63M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
910.34K
52W High
$ 5.66
52W Low
$ 0.78
Dividend Yield
0.00%
Beta
0.73
Technicals
50-Day MA
1.2182
200-Day MA
1.8957
52 Week High
5.66
52 Week Low
0.783
About VTYX
Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops oral therapies for patients with autoimmune, inflammatory, and neurodegenerative diseases.
Employees
81
Headquarters
San Diego, CA
CEO
Dr. Sheila K. Gujrathi M.D.
Latest News
Is Ventyx Biosciences (NASDAQ:VTYX) In A Good Position To Deliver On Growth Plans? - simplywall.st
2 weeks ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg